81 related articles for article (PubMed ID: 2403523)
1. Growth hormone inhibits activation of phosphatidylinositol phospholipase C by insulin in ob/ob mouse adipose tissue.
Chou SY; Kostyo JL; Adamafio NA
Endocrinology; 1990 Jan; 126(1):62-6. PubMed ID: 2403523
[TBL] [Abstract][Full Text] [Related]
2. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone inhibits activation of phosphatidylinositol phospholipase C in adipose plasma membranes: evidence for a growth hormone-induced change in G protein function.
Roupas P; Chou SY; Towns RJ; Kostyo JL
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1691-5. PubMed ID: 1848008
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
Towns R; Kostyo JL; Colca JR
Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
[TBL] [Abstract][Full Text] [Related]
5. The stimulatory effect of insulin on diacylglycerol generation in adipocyte membranes from ob/ob mice is impaired by growth hormone.
Towns R; Kostyo JL; Martin D; Chou SY; Bennink MR
Endocrinology; 1993 Apr; 132(4):1671-6. PubMed ID: 8462467
[TBL] [Abstract][Full Text] [Related]
6. Influence of cycloheximide on acute diabetogenic effects of S-carboxymethylated human growth hormone in obese (ob/ob) mice.
Adamafio NA; Cameron CM; Kostyo JL
Horm Metab Res; 1988 Jul; 20(7):391-4. PubMed ID: 3049288
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of S-carboxymethylated human growth hormone on insulin resistance in the obese (ob/ob) mouse.
Adamafio NA; Kostyo JL; Cameron CM; Trimark JR; Dunbar JC
Metabolism; 1988 Sep; 37(9):900-5. PubMed ID: 3047525
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance.
del Rincon JP; Iida K; Gaylinn BD; McCurdy CE; Leitner JW; Barbour LA; Kopchick JJ; Friedman JE; Draznin B; Thorner MO
Diabetes; 2007 Jun; 56(6):1638-46. PubMed ID: 17363744
[TBL] [Abstract][Full Text] [Related]
10. Altered signal transduction secondary to surface IgM cross-linking on B-chronic lymphocytic leukemia cells. Differential activation of the phosphatidylinositol-specific phospholipase C.
Hivroz C; Gény B; Brouet JC; Grillot-Courvalin C
J Immunol; 1990 Mar; 144(6):2351-8. PubMed ID: 2107258
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone increases phosphoinositide turnover in rat adipocytes that are sensitive to the insulin-like action of the hormone.
Eriksson H; Sundler R; Donnér J
Mol Cell Biochem; 1990 Sep; 97(2):181-6. PubMed ID: 2177835
[TBL] [Abstract][Full Text] [Related]
12. Effect of insulin and insulin-like growth factors I and II on phosphatidylinositol and phosphatidylinositol 4,5-bisphosphate breakdown in liver from humans with and without type II diabetes.
Thakker JK; DiMarchi R; MacDonald K; Caro JF
J Biol Chem; 1989 May; 264(13):7169-75. PubMed ID: 2540178
[TBL] [Abstract][Full Text] [Related]
13. Reduced and S-carboxymethylated human growth hormone: a probe for diabetogenic action.
Cameron CM; Kostyo JL; Rillema JA; Gennick SE
Am J Physiol; 1984 Nov; 247(5 Pt 1):E639-44. PubMed ID: 6496734
[TBL] [Abstract][Full Text] [Related]
14. Insulin activates phospholipase C-gamma1 via a PI-3 kinase dependent mechanism in 3T3-L1 adipocytes.
Eichhorn J; Kayali AG; Austin DA; Webster NJ
Biochem Biophys Res Commun; 2001 Mar; 282(2):615-20. PubMed ID: 11401505
[TBL] [Abstract][Full Text] [Related]
15. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
[TBL] [Abstract][Full Text] [Related]
16. Alteration of phosphoinositide degradation by cytosolic and membrane-bound phospholipases after forebrain ischemia-reperfusion in gerbil: effects of amyloid beta peptide.
Strosznajder J; Zambrzycka A; Kacprzak MD; Kopczuk D; Strosznajder RP
Neurochem Res; 1999 Oct; 24(10):1277-84. PubMed ID: 10492523
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
Salem MA; Wolff GL
Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
[TBL] [Abstract][Full Text] [Related]
18. Separation of early and late responses of adipose tissue to growth hormone.
Goodman HM
Endocrinology; 1981 Jul; 109(1):120-9. PubMed ID: 7016508
[TBL] [Abstract][Full Text] [Related]
19. Isolated adipocytes from growth hormone-treated obese (ob/ob) mice exhibit insulin resistance.
Roupas P; Towns RJ; Kostyo JL
Biochim Biophys Acta; 1990 May; 1052(2):341-4. PubMed ID: 2110483
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone maintains its own receptors in rat adipocytes.
Grichting G; Goodman HM
Endocrinology; 1986 Aug; 119(2):847-54. PubMed ID: 3015559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
